美国皮肤病学会-银屑病基金会联合指南：生物制剂治疗银屑病的管理与治疗。
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
机构信息
Baylor Scott and White, Dallas, Texas.
University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada.
出版信息
J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13.
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
银屑病是一种慢性、炎症性多系统疾病，影响美国人口的 3.2%。本指南针对银屑病管理和护理中出现的重要临床问题提供了建议，这些建议是基于现有证据得出的。本文将重点介绍生物制剂治疗银屑病的方法，包括治疗建议和皮肤科医生在监测和教育患者方面的作用，强调了解治疗获益和相关风险的重要性。
Zotero 插件